NEUROMERSIVE, INC — Department of Defense SBIR Phase II: SBIR PHASE II PROPOSAL F2-17023 - ENHANCING FLIGHT SAFETY, PERFORMANCE, AND PILOT READINES
NEUROMERSIVE, INC — SBIR Phase II award from Department of Defense.
Summary
Neuromersive Inc. received $1.25 million from the Air Force for a Phase II SBIR project using vestibular therapy to improve pilot balance, reduce motion issues, and enhance overall flight safety and readiness. The work targets practical treatments that help pilots perform better and stay mission-ready.
- Amount
- $1,248,073
- Agency
- Department of Defense · Department of the Air Force
- Program / Phase
- SBIR · Phase II
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- TX
- Period
- 2024-06-14 → 2026-09-15
Technology domains
Description
SBIR PHASE II PROPOSAL F2-17023 - ENHANCING FLIGHT SAFETY, PERFORMANCE, AND PILOT READINESS THROUGH VESTIBULAR THERAPY